CS Paper Radar

PMO-Dock: Benchmarking Docking, Specificity, and Generalization in Molecular Optimization

Gor Simonyan, Tatevik Abrahamyan, Narek Abelyan, Tigran Fahradyan, Hrant Khachatrian

cs.LG q-bio.QM ·submitted 2026-10-13 18:07 UTC · v2
benchmark

Abstract

The Practical Molecular Optimization (PMO) benchmark standardized evaluation in molecular optimization, but it is built on simple property-based oracles that do not capture structure-based drug design. As the field has moved to docking-based objectives, evaluation practice has become unstandardized, and different methods report results on different docking tasks, often without a shared protocol for fair comparison or sample-efficiency constraints. To address this, we introduce Practical Molecular Optimization for Docking (PMO-Dock), a benchmark and protocol for docking-based optimization consisting of 25 tasks covering hit generation, lead optimization, and a new specificity task requiring strong on-target binding while penalizing off-target interactions. The protocol separates model development from final evaluation: validation tasks are used for hyperparameter tuning, and test tasks are held out for final evaluation and are not used during development. Evaluation on the test tasks is done under a strict oracle budget to reflect realistic drug-discovery settings. We benchmark four diverse high-performing methods spanning different optimization paradigms, Saturn (reinforcement learning), GenMol (discrete diffusion), Genetic-guided GFlowNet, and ChemLlama (LLM-based evolutionary search). Our results show no universally best method across tasks, additional analyses of hyperparameter transfer (cross-task and cross-category) and sensitivity show that transfer is often limited and varies by method, motivating method-dependent selection strategies. This benchmark provides a concrete standard for evaluating generalization to unseen tasks and sample efficiency under a limited test-time oracle budget.

Closest papers

Nearest neighbours by meaning across the whole index.

Binding Mode Matters: Hotspot-Aware Drug Discovery via Explorative Preferences

cs.LG cs.AI ·2026-11-11 ·Dingshuo Chen, Hao Yang, Kuangqi Zhou, Zhixun Li, Qiang Liu +3 more
top venue similarity 0.71
Abstract · To appear at NeurIPS 2026, 26 pages

Discovering hit molecules requires not just high binding affinity, but also the identification of diverse binding modes, which are critical for experimental assays. Existing generative approaches have predominantly relied on optimizing a scalar docking score, obscuring the distinct contributions of key binding determinants. To this end, we introduce a paradigm shift by formulating target-based drug design as a multi-objective exploration task, where each objective explicitly corresponds to enhancing interactions with a specific hotspot. Here, we introduce BindMol, a novel generative framework driven by a customized multi-objective reinforcement learning algorithm. By incorporating explorative preferences during training, our approach efficiently uncovers molecules with diverse and desirable binding profiles. Empirical results demonstrate that BindMol facilitates the discovery of high-affinity compounds characterized by both structural novelty and diverse binding modes. Validated across target-based drug discovery and multi-property optimization tasks, our approach provides a versatile paradigm for goal-oriented drug discovery.

0.36

SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity

cs.AI ·2026-09-18 ·Thao Nguyen, Heng Ji
benchmark similarity 0.69
Abstract

Off-target protein binding is a major source of adverse effects for small-molecule drugs, yet most structure-based molecular design methods focus on generating selective compounds de novo rather than improving the selectivity of existing, well- characterized drugs. We introduce specificity optimization (SpecOpt), a molecular design task that seeks constrained structural modifications to an existing compound that increase its binding preference for an intended target over known off-targets while preserving its structural identity and drug-like properties. To enable systematic evaluation, we construct a ChEMBL-derived benchmark from compound-target interaction data, identifying intended targets through curated drug-mechanism annotations and off- targets through measured activities. We then develop an agentic framework that docks each compound against its intended target and off-targets, compares the resulting poses through residue-aware atom-protein contacts, and provides these differential interactions to a large language model to propose targeted structural modifications. Candidates are retained only if they satisfy molecular similarity, ADMET, and target-off-target docking selectivity criteria. On 915 compounds, the agent improves the target- off-target binding gap for 84.8% of compounds, shifting the mean gap from -0.72 to +0.47 kcal/mol while maintaining a mean Tanimoto similarity of 0.72 to the starting compounds. Ablation studies identify residue-specific contact information as the critical optimization signal: replacing residue identities with binary contact indicators eliminates improvement on all 29 ablation compounds. These results establish SpecOpt as a distinct molecular design problem and demonstrate residue-aware differential interactions as an effective signal for improving the specificity of existing compounds.

0.08

One Sequence, Many Decodings: CAGenMol-2 Recasts Drug Design as Masked Molecular Inference

cs.LG cs.AI ·2026-09-28 ·Yanting Li, Enyan Dai, Lei Wang, Wen-Cai Ye, Li Liu
similarity 0.69
Abstract

Drug design couples property evaluation, conditional generation, structure-based design, and local optimization, yet machine learning systems typically address these capabilities with separate task-specific models. We introduce CAGenMol-2, a masked diffusion molecular language model that represents molecules, continuous scalar properties, and 3D protein pockets within a single wrapped sequence. Within this pretrained interface, downstream operations are selected by which sequence regions are observed or masked at inference, allowing one checkpoint to perform property prediction, property- and pocket-conditioned generation, and partial-constraint design without task-specific architectures or backbone fine-tuning. We further propose Adaptive Fragment Optimization (AdaFO), a gradient-free mask-and-refill search that turns the masked decoder into an iterative local molecular optimizer. On CrossDocked2020, AdaFO increases Success Rate from 30.2\% to 70.8\%, the best reported under this protocol, while largely preserving drug-likeness and diversity. Finally, scaffold-preserving directional editing and CRBN/VHL case studies demonstrate its use in compound design workflows spanning local molecular editing, structure-based prioritization, and downstream simulation-based screening.

0.15

SurfSpec: Enhancing Off-Target-Agnostic Specificity by Bounding Pocket-Ligand Geometric Mismatch

cs.LG q-bio.QM ·2026-09-02 ·Minyeong Hwang, Yoorim Gang, Ziseok Lee, Wooyeol Lee, Young Bin Park +3 more
theoryhot direction similarity 0.68
Abstract

Lead optimization in structure-based drug design aims to improve target binding while avoiding unintended interactions with off-target pockets. However, existing affinity-driven methods do not explicitly control specificity, whereas current specificity-aware approaches commonly require prior knowledge of off-target structures. We address off-target-agnostic specificity-aware lead optimization by analyzing the geometric mismatch between a ligand and the target pocket. We provide a conservative specificity lower bound for geometrically separated off-targets without requiring access to off-target structures. By metricizing pocket--ligand mismatch, the triangle inequality shows that reducing target--ligand mismatch improves a conservative lower bound on mismatch to a separated off-target class, which can be translated into a specificity lower bound through an empirical geometry--affinity calibration. Motivated by this analysis, we introduce SurfSpec, an off-target-agnostic lead optimization framework that iteratively grows ligands toward under-occupied regions of the target pocket surface. SurfSpec alternates between linker generation toward selected target-surface patches, which provides geometric pseudo-labels, and refinement under a pocket-conditioned ligand prior, which restores these pseudo-labels into valid ligands. On the CrossDocked2020 test set, SurfSpec reduces geometric mismatch and outperforms evaluated off-target-agnostic lead optimization baselines in empirical specificity, while maintaining competitive target-affinity improvement.

0.30

A Modular Agentic Framework for Synthetically Constrained Multi-Objective Hit-to-Lead Optimization

cs.AI cs.LGq-bio.QM ·2026-08-11 ·Kelvin P. Idanwekhai, Enes Kelestemur, Benjamin Strickland, Matthew Hart, Steini Davidsson +4 more
code/data similarity 0.68
Abstract · 22 pages, 9 figures

Hit-to-lead optimization requires iterative design of hit analogs across competing potency, selectivity, physicochemical, pharmacokinetic, safety, and synthetic constraints. We present SABLE (Synthetically-accessible Agentic Bayesian Ligand Exploration), an open-source framework that employs natural-language orchestration to guide chemical structure optimization. SABLE uses an LLM to interpret user-defined goals and route tasks, while specialized tools perform reaction-templated analog enumeration, physicochemical and ADMET property prediction, structure-based affinity scoring, and Bayesian optimization. The resulting workflow is a computational twin of the analytical and prioritization stages of the design-make-test-analyze cycle, providing provenance of each numerical output. Across single, and multi-objective optimization studies, SABLE enriches candidate sets for user-defined computational objectives while evaluating only a subset of the enumerated search space. Its modular architecture allows tools and characterization backends to be replaced by editing a simple config file, without modifying operational logic. SABLE provides an extensible decision-support framework for prioritizing synthetically constrained analogs in early-stage drug discovery.

0.26

What Are LLM Agents Actually Learning on Low-Budget Molecular Optimization Benchmarks?

cs.LG ·2026-10-30 ·Jiayu Qin, Zhengquan Luo, Changyou Chen, Zhiqiang Xu
top venuebenchmarktheory similarity 0.68
Abstract

Recent work reports large gains for LLM agents on low-budget molecular optimization. We measure the contributions of online optimization, retrievable task information, and permissive oracle landscapes. On PMO at 50 oracle calls, a GPT-4o mini agent's sum AUC falls from 14.44 to 4.85 after task names and curated reference compounds are hidden. An identity-blinded condition that states only the oracle form (e.g., similarity to a hidden reference) scores 5.39, while a deterministic retrieval-only baseline with no LLM reaches 12.16 (84% of the full agent). A full 23-task 2x2 ablation and a three-seed replication on eight tasks support this interpretation. On a protein-targeted benchmark with an AutoDock Vina composite oracle, a single-edit random walk is a strong lower bound; across three seeds it obtains composite 0.636 +/- 0.008 and docking improvement -1.11 +/- 0.04 kcal/mol. As a positive control, a retrieval-free population agent exceeds REINVENT at a matched 50-call AUC budget, with its strongest result at 100 calls. These results motivate two inexpensive sanity checks: retrieval-safe PMO prompts and a random-walk floor for docking-based optimization.

0.28

Which reported inputs govern molecular docking reproducibility? A benchmark from reporting audit to independent re-execution

cs.DL ·2026-09-29 ·Giap Duc Ha
benchmark similarity 0.67
Abstract · 29 pages, 8 figures, 6 tables. Retained derived data, verification code and source limitations included as ancillary files

Computational docking results can be re-executed only when the molecular system and protocol are specified, yet reporting checklists do not quantify how strongly individual method fields affect the reported score. We combined a span-verified audit of 50 open-access papers with controlled one-factor perturbations, a Vinardo scoring-function check and a Vina cross-docking extension covering 12 targets in 7 protein families, and re-execution of 37 published claims on local and independent cloud infrastructure. Search-related fields were sparsely reported, but perturbing box centre, box size, exhaustiveness or random seed produced median absolute score changes of no more than 0.08 kcal mol$^{-1}$; ligand protonation and identity produced median changes of 0.19 and 0.29 kcal mol$^{-1}$, respectively, whereas receptor structure produced the largest change (1.02 kcal mol$^{-1}$; n = 85; P < 0.001), and 22% of 116 unique reported ligand strings remained unresolved or ambiguous after deterministic name normalization. These measurements yielded empirical field weights for the NewScience Evidence score and identified exact receptor structure, machine-resolvable ligand identity and protonation state as primary reporting elements; 29 of 37 local and 27 of 37 cloud re-executions were within 2.0 kcal mol$^{-1}$ of the reported score, but these descriptive rates do not estimate experimental replication or a calibrated probability of reproduction.

0.28

MFG: Multi-turn Feedback Guided Molecular Optimization

cs.AI cs.LGq-bio.QM ·2026-10-13 ·Trieu Nguyen, Frazier N. Baker, Ruoxi Gao, Daniel Adu-Ampratwum, Xia Ning
similarity 0.67
Abstract

Multi-objective molecular optimization is a critical process in drug discovery that aims to modify a given molecule to simultaneously improve multiple properties while maintaining a similar overall structure. This process often requires iterative modifications guided by computational or experimental feedback. Recent large language model (LLM)-based methods have begun to explore this iterative approach; however, these methods are not explicitly trained to leverage such feedback, while existing approaches primarily focus on single-turn molecular optimization. To address this gap, we introduce Multi-turn Feedback Guided (MFG) molecular optimization, a reinforcement learning framework that trains an LLM to progressively optimize molecules using feedback from previous turns. MFG introduces a feedback vector capturing both property improvements and source molecule similarity, alongside a feedback-aligned reward function that promotes progressive improvement across turns. We apply MFG over $\text{GeLLM}^{3}\text{O}$, a state-of-the-art LLM model for multi-objective molecular optimization, evaluate $\text{GeLLM}^{3}\text{O-MFG}$ on ten multi-objective molecular optimization tasks. The results demonstrate that $\text{GeLLM}^{3}\text{O-MFG}$ achieves the highest average similarity-constrained success rate ($81.50%$), outperforming the base model $\text{GeLLM}^{3}\text{O}$ ($70.81%$).

0.17